Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 207.00
Bid: 206.00
Ask: 206.50
Change: 1.50 (0.73%)
Spread: 0.50 (0.243%)
Open: 202.50
High: 207.00
Low: 202.50
Prev. Close: 205.50
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

27 Sep 2023 07:00

RNS Number : 7484N
TP ICAP Group plc
27 September 2023
 

Transaction in Own Shares

TP ICAP Group PLC (the "Company") announces that it has purchased to be held in treasury (through Peel Hunt LLP acting as the Company's broker) the following number of its shares of 25p each on the London Stock Exchange.

Date of purchase:

26 September 2023

Number of shares purchased (aggregated volume):

34,981

Highest price paid per share (pence):

168.9

Lowest price paid per share (pence):

166.0

Volume weighted average price paid per share (pence):

167.2

Following the purchase of these shares, the Company's issued ordinary share capital consists of 788,670,932 ordinary shares of which a total of 3,460,636 shares are held in treasury. The remaining 785,210,296 shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Peel Hunt as part of the Share Buyback Programme.

Aggregate information:

 

Trading Venue

Volume-weighted average price paid per share (Gbp)

Aggregated number of shares purchased

London Stock Exchange (XLON)

 167.2140

 34,981

Total

 167.2140

 34,981

Individual transactions:

Number of shares purchased

Transaction price (Gbp)

Market / Sytematic Internaliser

Time of transaction

1,397

167.9

XLON

08:09:29

153

167.9

XLON

08:09:29

358

166.9

XLON

08:09:35

1,000

166.9

XLON

08:09:35

460

166

XLON

08:11:25

918

166

XLON

08:11:27

706

166

XLON

08:12:40

716

166

XLON

08:13:52

587

166.1

XLON

08:21:54

70

166.1

XLON

08:21:54

783

166.1

XLON

08:22:00

1,472

166.1

XLON

08:49:42

939

167.9

XLON

09:50:20

504

167.9

XLON

09:50:20

1,536

167.5

XLON

09:50:22

1,426

167

XLON

09:50:25

384

167

XLON

10:05:36

1,228

167

XLON

10:44:31

1,427

166.7

XLON

10:44:44

1,521

166.6

XLON

10:44:45

1,398

166.4

XLON

10:44:47

1,215

166.5

XLON

10:58:00

123

166.5

XLON

10:58:00

215

166.5

XLON

10:58:00

192

166.7

XLON

11:07:35

800

166.7

XLON

11:07:35

357

166.7

XLON

11:07:41

246

166.5

XLON

11:25:20

708

167.2

XLON

12:18:13

1,354

167.4

XLON

13:33:42

1,511

167.6

XLON

14:05:51

1,439

168.1

XLON

14:41:40

1,582

168

XLON

14:42:18

9

168

XLON

14:42:18

131

168.1

XLON

15:13:51

1,394

168.1

XLON

15:13:51

352

168

XLON

15:16:23

1,030

168

XLON

15:16:23

1,333

168.4

XLON

15:51:12

1,483

168.4

XLON

15:57:56

20

168.9

XLON

16:27:50

504

168.9

XLON

16:29:49

 

Enquiries:

TP ICAP Group Plc

 

Vicky Hart

Group Company Secretary

Email: companysecretarial@tpicap.com

 

Dominic Lagan

Head of Investor Relations

Direct: +44 (0) 20 3933 0447

Email: Dominic.Lagan@tpicap.com

Peel Hunt LLP (Joint Broker) Telephone: +44 (0) 20 7418 8900

Andrew Buchanan, Rob Parker

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKABDFBKDCCB
Date   Source Headline
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change
13th Dec 20189:22 amRNSHolding(s) in Company
4th Dec 20184:15 pmRNSHolding(s) in Company
3rd Dec 20183:59 pmRNSHolding(s) in Company
16th Nov 20184:08 pmRNSHolding(s) in Company
16th Nov 20183:42 pmRNSDirector Declaration
14th Nov 201812:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.